Sirnaomics宣佈完成針對靶向APOC3用於治療心血管疾病的STP125G 在非人靈長類動物模型中安全性和有效性的IND準備階段研究 Jul 23, 2024 17:52 HKT/SGT Read More
Avance Clinical Appoints Asia Regional Director as Part of Global Expansion Program Jul 23, 2024 16:00 HKT/SGT Read More
Q&M Dental Group Advanced "Treatment Plan" AI-Module Released Today Jul 23, 2024 10:30 HKT/SGT Read More
Lexaria Receives New Patents For Antiviral Drug Delivery and for Treating Epilepsy Jul 08, 2024 21:10 HKT/SGT Read More
Eisai Announces Move to Solo Development and Commercialization of Farletuzumab Ecteribulin (FZEC) Antibody Drug Conjugate (ADC) Jul 02, 2024 12:01 HKT/SGT Read More
CGFNS International Announces First Global Credential for Rehab Nurses Jun 28, 2024 06:00 HKT/SGT Read More
HighTide Therapeutics Presents Analyses of a Phase 2 T2DM Study at the ADA Scientific Sessions, Highlighting Glycemic and Cardiometabolic Benefits of Berberine Ursodeoxycholate (HTD1801) Jun 21, 2024 18:30 HKT/SGT Read More
Eisai Continues Contract for FY2024 Dementia Examination Project by Tokyo Bunkyo City Jun 21, 2024 14:35 HKT/SGT Read More
FDA Accepts Eisai's Filing of LEQEMBI (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease Jun 10, 2024 17:50 HKT/SGT Read More
エーザイとバイオジェン、早期アルツハイマー病治療剤「レケンビ(R)」の静注維持投与に関する生物製剤承認一部変更申請が米国FDAにより受理 Jun 10, 2024 13:00 JST Read More
君圣泰医药将在2024年国际肝病大会发布MASH临床2a期研究分析结果,进一步展现熊去氧胆小檗碱(HTD1801)的疗效与安全性 Jun 05, 2024 09:00 HKT/SGT Read More
君聖泰醫藥將在2024年國際肝病大會發布MASH臨床2a期研究分析結果,進一步展現熊去氧膽小檁鹼(HTD1801)的療效與安全性 Jun 05, 2024 09:00 HKT/SGT Read More